Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Start-Up Licensing Flexible Genome-Editing Technology

A start-up biotechnology company is licensing techniques from two universities that make genome editing more flexible and better control gene expression. . . . → Read More: Start-Up Licensing Flexible Genome-Editing Technology

NIH Funds Seen Boosting Industry Patents

An analysis of grants issued by National Institutes of Health shows a large percentage of those grants, directly or indirectly, result in patented technologies in industry. . . . → Read More: NIH Funds Seen Boosting Industry Patents

CARB-X Commits $48M for Antibiotic Resistance R&D

A public-private partnership is spending $48 million in grants to biotechnology companies for research on treatments and diagnostics to counter antibiotic resistance, with half of that amount distributed immediately. . . . → Read More: CARB-X Commits $48M for Antibiotic Resistance R&D

Univ. Spin-Off Designing Heart Disease Screening App

A spin-off enterprise from Massachusetts Institute of Technology is creating a system using a smartphone camera to detect heart rhythm problems that lead to a stroke. . . . → Read More: Univ. Spin-Off Designing Heart Disease Screening App

FDA Approves Multiple Sclerosis Therapy

The Food and Drug Administration approved a synthetic targeted antibody to treat multiple sclerosis in people with relapsing or steadily worsening forms of the disease. . . . → Read More: FDA Approves Multiple Sclerosis Therapy

Climate-Resistant Oilseed Crop Plant Developed

An academic-industry team developed a new crop plant variety that produces cooking oil like rapeseed or canola, but in a warmer and dryer climate. . . . → Read More: Climate-Resistant Oilseed Crop Plant Developed

Univ. of California to Gain European Crispr-Cas9 Patent

A patent dispute among top research universities took another turn, as the European Patent Office announced its intention to grant a patent to University of California for its genome editing techniques. . . . → Read More: Univ. of California to Gain European Crispr-Cas9 Patent

Diet Enhancing Gut Microbes Shown to Slow Type 1 Diabetes

A diet that produces certain short-chain fatty acids in the gut is shown in lab mice to support the immune system and slow the onset of type 1 diabetes. . . . → Read More: Diet Enhancing Gut Microbes Shown to Slow Type 1 Diabetes

Trials, Registry Planned for Wound Care Device

A company making products for healing wounds is studying the ways one of its dressings is used in the field, to better understand the product’s role in wound care. . . . → Read More: Trials, Registry Planned for Wound Care Device

T-Cell Therapy Trial Begins for Autoimmune Diseases

A biotechnology company began testing on humans an experimental drug to increase healthy T-cells in the immune system for people with autoimmune disorders. . . . → Read More: T-Cell Therapy Trial Begins for Autoimmune Diseases